US 9333244
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
granted A61KA61K38/47A61K9/0034
Quick answer
US patent 9333244 (Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia) held by HALOZYME, INC. expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HALOZYME, INC.
- Grant date
- Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 72
- CPC classes
- A61K, A61K38/47, A61K9/0034, A61K9/127, A61P